Download PDF
J Knee Surg 2018; 31(09): 913-918
DOI: 10.1055/s-0038-1625957
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

A Study of Coagulation Changes at Early Stage after Total Knee Arthroplasty

Jian Huang
1   Department of Orthopaedics, Liaocheng People's Hospital and Liaocheng Clinical School of Taishan Medical University, Liaocheng, Shandong, People's Republic of China
,
Peng Zhang
1   Department of Orthopaedics, Liaocheng People's Hospital and Liaocheng Clinical School of Taishan Medical University, Liaocheng, Shandong, People's Republic of China
,
Dawei Wang
1   Department of Orthopaedics, Liaocheng People's Hospital and Liaocheng Clinical School of Taishan Medical University, Liaocheng, Shandong, People's Republic of China
› Author Affiliations Funding None.
Further Information

Publication History

04 August 2017

23 December 2017

Publication Date:
30 January 2018 (online)

    Permissions and Reprints

Abstract

Coagulation changes after total knee arthroplasty (TKA) can provide evidence for optimization of timing of perioperative anticoagulation medicine. To evaluate the changes, 50 patients with knee osteoarthritis or rheumatoid arthritis were recruited for the study and underwent thrombelastography tests pre-, 6 hours, 12 hours, and 24 hours after TKA surgery and Doppler ultrasound examination 20 to 24 hours after surgery. The results have shown prolonged clotting time (R value) at 6 and 12 hours, while shortened at 24 hours. Similar results have been found in combined clotting and coagulation time (R + K value). However, other parameters, such as coagulation time (K value), coagulation speed (α angle), maximum amplitude (MA), and coagulation index (CI), have not significantly changed except that CI has increased significantly at 24 hours. Further Doppler ultrasound examination did not detect any deep venous thrombosis in all patients. The data showed that coagulation time after TKA within 12 hours, especially within the 6-hour time period, after surgery was significantly higher, while at 24 hours it became lower than the preoperation time. The results suggested that anticoagulation medicine is not necessary during the first 6 to 12 hours, but is required between 12 and 24 hours after surgery to reduce the risk of thrombosis.

Keywords

coagulation changes - knee arthroplasty - coagulation index - Doppler ultrasound
 

  • References

  • 1 Zuckerman JD. Inpatient rehabilitation after total joint replacement. JAMA 1998; 279 (11) 880
    CrossrefPubMedGoogle Scholar
  • 2 Song K, Rong Z, Yao Y, Shen Y, Zheng M, Jiang Q. Metabolic syndrome and deep vein thrombosis after total knee and hip arthroplasty. J Arthroplasty 2016; 31 (06) 1322-1325
    CrossrefPubMedGoogle Scholar
  • 3 Levy YD, Hardwick ME, Copp SN, Rosen AS, Colwell Jr CW. Thrombosis incidence in unilateral vs. simultaneous bilateral total knee arthroplasty with compression device prophylaxis. J Arthroplasty 2013; 28 (03) 474-478
    CrossrefPubMedGoogle Scholar
  • 4 Shimoyama Y, Sawai T, Tatsumi S. , et al. Perioperative risk factors for deep vein thrombosis after total hip arthroplasty or total knee arthroplasty. J Clin Anesth 2012; 24 (07) 531-536
    CrossrefPubMedGoogle Scholar
  • 5 Miric A, Lombardi P, Sculco TP. Deep vein thrombosis prophylaxis: a comprehensive approach for total hip and total knee arthroplasty patient populations. Am J Orthop 2000; 29 (04) 269-274
    PubMedGoogle Scholar
  • 6 Guan ZP, Lü HS, Chen YZ, Song YN, Qin XL, Jiang J. Clinical risk factors for deep vein thrombosis after total hip and knee arthroplasty. Zhonghua Wai Ke Za Zhi 2005; 43 (20) 1317-1320
    PubMedGoogle Scholar
  • 7 Pookarnjanamorakot C, Sirisriro R, Eurvilaichit C, Jaovisidha S, Koysombatolan I. The incidence of deep vein thrombosis and pulmonary embolism after total knee arthroplasty: the screening study by radionuclide venography. J Med Assoc Thai 2004; 87 (08) 869-876
    PubMedGoogle Scholar
  • 8 Nathan S, Aleem MA, Thiagarajan P, Das De S. The incidence of proximal deep vein thrombosis following total knee arthroplasty in an Asian population: a Doppler ultrasound study. J Orthop Surg (Hong Kong) 2003; 11 (02) 184-189
    CrossrefPubMedGoogle Scholar
  • 9 Kim YH, Kim JS. Incidence and natural history of deep-vein thrombosis after total knee arthroplasty. A prospective, randomised study. J Bone Joint Surg Br 2002; 84 (04) 566-570
    CrossrefPubMedGoogle Scholar
  • 10 Wang CJ, Wang JW, Chen LM, Chen HS, Yang BY, Cheng SM. Deep vein thrombosis after total knee arthroplasty. J Formos Med Assoc 2000; 99 (11) 848-853
    PubMedGoogle Scholar
  • 11 Chung LH, Chen WM, Chen CF, Chen TH, Liu CL. Deep vein thrombosis after total knee arthroplasty in Asian patients without prophylactic anticoagulation. Orthopedics 2011; 34 (01) 15
    PubMedGoogle Scholar
  • 12 Kimura K, Ohtani S, Okamura H, Ishii N, Kishimoto C, Konishi K. Anticoagulation therapy with heparin and warfarin in total knee arthroplasty for osteoarthritis knee. Clin Appl Thromb Hemost 2009; 15 (01) 109-112
    CrossrefPubMedGoogle Scholar
  • 13 Zimlich RH, Fulbright BM, Friedman RJ. Current status of anticoagulation therapy after total hip and total knee arthroplasty. J Am Acad Orthop Surg 1996; 4 (02) 54-62
    CrossrefPubMedGoogle Scholar
  • 14 Buckner TW, Leavitt AD, Ragni M. , et al. Prospective, multicenter study of postoperative deep-vein thrombosis in patients with haemophilia undergoing major orthopaedic surgery. Thromb Haemost 2016; 116 (01) 42-49
    Article in Thieme ConnectPubMedGoogle Scholar
  • 15 Barna L, Triplett DA. Use of the activated partial thromboplastin time for the diagnosis of congenital coagulation disorders: problems and possible solutions. Ric Clin Lab 1989; 19 (04) 345-354
    PubMedGoogle Scholar
  • 16 Dudek MM, Kent N, Gustafsson KM, Lindahl TL, Killard AJ. Fluorescence-based blood coagulation assay device for measuring activated partial thromboplastin time. Anal Chem 2011; 83 (01) 319-328
    CrossrefPubMedGoogle Scholar
  • 17 Turi DC, Peerschke EI. Sensitivity of three activated partial thromboplastin time reagents to coagulation factor deficiencies. Am J Clin Pathol 1986; 85 (01) 43-49
    CrossrefPubMedGoogle Scholar
  • 18 Despotis GJ, Santoro SA, Spitznagel E. , et al. On-site prothrombin time, activated partial thromboplastin time, and platelet count. A comparison between whole blood and laboratory assays with coagulation factor analysis in patients presenting for cardiac surgery. Anesthesiology 1994; 80 (02) 338-351
    CrossrefPubMedGoogle Scholar
  • 19 Dager WE, Gosselin RC, Kitchen S, Dwyre D. Dabigatran effects on the international normalized ratio, activated partial thromboplastin time, thrombin time, and fibrinogen: a multicenter, in vitro study. Ann Pharmacother 2012; 46 (12) 1627-1636
    CrossrefPubMedGoogle Scholar
  • 20 Daniels AH, Kawaguchi S, Contag AG. , et al. Hospital charges associated with “never events”: comparison of anterior cervical discectomy and fusion, posterior lumbar interbody fusion, and lumbar laminectomy to total joint arthroplasty. J Neurosurg Spine 2016; 25 (02) 165-169
    CrossrefPubMedGoogle Scholar
  • 21 Wikkelsø A, Wetterslev J, Møller AM, Afshari A. Thromboelastography (TEG) or rotational thromboelastometry (ROTEM) to monitor haemostatic treatment in bleeding patients: a systematic review with meta-analysis and trial sequential analysis. Anaesthesia 2017; 72 (04) 519-531
    CrossrefPubMedGoogle Scholar
  • 22 Müller MC, Meijers JC, Vroom MB, Juffermans NP. Utility of thromboelastography and/or thromboelastometry in adults with sepsis: a systematic review. Crit Care 2014; 18 (01) R30
    CrossrefPubMedGoogle Scholar
  • 23 Dai Y, Lee A, Critchley LA, White PF. Does thromboelastography predict postoperative thromboembolic events? A systematic review of the literature. Anesth Analg 2009; 108 (03) 734-742
    CrossrefPubMedGoogle Scholar
  • 24 Bolliger D, Seeberger MD, Tanaka KA. Principles and practice of thromboelastography in clinical coagulation management and transfusion practice. Transfus Med Rev 2012; 26 (01) 1-13
    CrossrefPubMedGoogle Scholar
  • 25 Bhardwaj V, Malhotra P, Hasija S, Chowdury UK, Pangasa N. Coagulopathies in cyanotic cardiac patients: an analysis with three point-of-care testing devices (Thromboelastography, rotational thromboelastometry, and sonoclot analyzer). Ann Card Anaesth 2017; 20 (02) 212-218
    CrossrefPubMedGoogle Scholar
  • 26 Shore-Lesserson L, Manspeizer HE, DePerio M, Francis S, Vela-Cantos F, Ergin MA. Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesth Analg 1999; 88 (02) 312-319
    CrossrefPubMedGoogle Scholar
  • 27 Franchi F, Hammad JS, Rollini F. , et al. Role of thromboelastography and rapid thromboelastography to assess the pharmacodynamic effects of vitamin K antagonists. J Thromb Thrombolysis 2015; 40 (01) 118-125
    CrossrefPubMedGoogle Scholar
  • 28 Bachli EB, Bösiger J, Béchir M. , et al. Thromboelastography to monitor clotting/bleeding complications in patients treated with the molecular adsorbent recirculating system. Crit Care Res Pract 2011; 2011: 313854
    PubMedGoogle Scholar
  • 29 Ti LK, Cheong KF, Chen FG. Prediction of excessive bleeding after coronary artery bypass graft surgery: the influence of timing and heparinase on thromboelastography. J Cardiothorac Vasc Anesth 2002; 16 (05) 545-550
    CrossrefPubMedGoogle Scholar
  • 30 Essell JH, Martin TJ, Salinas J, Thompson JM, Smith VC. Comparison of thromboelastography to bleeding time and standard coagulation tests in patients after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1993; 7 (04) 410-415
    CrossrefPubMedGoogle Scholar
  • 31 Gonzalez E, Moore EE, Moore HB. Management of trauma-induced coagulopathy with thrombelastography. Crit Care Clin 2017; 33 (01) 119-134
    CrossrefPubMedGoogle Scholar
  • 32 Huang SY, Kim CY, Miller MJ. , et al. Abdominopelvic and lower extremity deep venous thrombosis: evaluation with contrast-enhanced MR venography with a blood-pool agent. Am J Roentgenol 2013; 201 (01) 208-214
    CrossrefPubMedGoogle Scholar
  • 33 Perseghin P, Beverina I, Bongiorno U, Calvisi V, Branca A. Blood transfusion and deep venous thrombosis in primary total hip and knee replacement surgery: a retrospective analysis of 339 patients. Transfus Sci 1996; 17 (03) 397-406
    CrossrefPubMedGoogle Scholar
  • 34 Harbourne T, Nicolaides AN. Estimation of fibrinolytic activity of whole blood in patients with recurrent idiopathic deep venous thrombosis. J Vasc Surg 1986; 4 (01) 1-4
    PubMedGoogle Scholar
  • 35 Törngren S. Prophylaxis of postoperative deep venous thrombosis. Studies on low-dose heparin, blood coagulation, infection as a risk factor and the half-life of fibrinogen in patients after gastrointestinal surgery. Acta Chir Scand Suppl 1979; 495: 1-69
    PubMedGoogle Scholar
  • 36 Hartert H. Clinical studies on blood coagulation with thrombelastography. II. The thrombocytopathies. Dtsch Arch Klin Med 1952; 199 (03) 293-311
    PubMedGoogle Scholar
  • 37 Hartert H. Thrombelastography, a method for physical analysis of blood coagulation. Z Gesamte Exp Med 1951; 117 (02) 189-203
    CrossrefPubMedGoogle Scholar
  • 38 Yang Y, Yao Z, Dai W, Shi P, Luo L, Zhang C. Changes of thrombelastography in patients undergoing elective primary total knee and total hip replacement with low molecular heparin prophylaxis. J Orthop Surg 2014; 9: 52
    CrossrefPubMedGoogle Scholar